High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer Academic Article uri icon

Overview

MeSH Major

  • Brachytherapy
  • Carcinoma, Squamous Cell
  • Head and Neck Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • HDR-IORT combined with radical surgical resection is associated with durable IFPFS and long-term overall survival in select patients with acceptable treatment-related morbidity. IORT dose >15Gy should be used to increase the likelihood of disease control. The ability to achieve in-field local control in this poor prognostic cohort was associated with improved survival outcomes.

publication date

  • March 11, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.brachy.2013.01.165

PubMed ID

  • 23466361

Additional Document Info

start page

  • 228

end page

  • 34

volume

  • 12

number

  • 3